← Eichor
Study identifier: NCT07102082 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Condition: Smoking Behaviors  ·  Sponsor: Roswell Park Cancer Institute

PhaseNA
Planned participants160
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersYes

About this study

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

This description comes directly from the study's public registry record.

Talk to the study team

ASK RPCI  ·  1-800-767-9355  ·  askroswell@roswellpark.org

Always discuss trial participation with your own doctor first.

Locations (1)

Roswell ParkBuffalo, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07102082